ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 206,99
0,31%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Arecor Therapeutics Plc (AREC)

  7. Arecor Therapeutics Plc (AREC) Actualités

AREC

Arecor Therapeutics (AREC)

Arecor Therapeutics Plc
De:
Trier par:
 Showing the most relevant articles for your search:LSE:AREC
DateHeureSourceTitreSymboleSociété
10/06/202410h54Alliance NewsAlliance NewsArecor Therapeutics shares dive as says needs funding in third quarterLSE:ARECArecor Therapeutics Plc
10/06/202408h00RNS Regulatory NewsArecor Therapeutics PLC Trading and Funding UpdateLSE:ARECArecor Therapeutics Plc
31/05/202417h05RNS Regulatory NewsArecor Therapeutics PLC Posting of 2023 Annual Report and Notice of AGMLSE:ARECArecor Therapeutics Plc
23/05/202408h00RNS Regulatory NewsArecor Therapeutics PLC Grant of Options and PDMR DealingLSE:ARECArecor Therapeutics Plc
21/05/202408h00RNS Regulatory NewsArecor Therapeutics PLC Arecor to host company and KOL webinar todayLSE:ARECArecor Therapeutics Plc
20/05/202410h58Alliance NewsAlliance NewsArecor Therapeutics hails positive profile for insulin AT278LSE:ARECArecor Therapeutics Plc
20/05/202408h00RNS Regulatory NewsArecor Therapeutics PLC Positive headline results for AT278 clinical trialLSE:ARECArecor Therapeutics Plc
16/05/202415h32Alliance NewsAlliance NewsEARNINGS AND TRADING: Michelmersh continues with positive order intakeLSE:ARECArecor Therapeutics Plc
16/05/202408h00RNS Regulatory NewsArecor Therapeutics PLC Final results for 2023LSE:ARECArecor Therapeutics Plc
14/05/202411h17RNS Regulatory NewsArecor Therapeutics PLC Notice of ResultsLSE:ARECArecor Therapeutics Plc
09/05/202418h18Alliance NewsAlliance NewsArecor Therapeutics collaborates with Medtronic on novel insulinLSE:ARECArecor Therapeutics Plc
09/05/202408h00RNS Regulatory NewsArecor Therapeutics PLC Arecor and Medtronic Diabetes collaborationLSE:ARECArecor Therapeutics Plc
03/05/202419h02Alliance NewsAlliance NewsIN BRIEF: Arecor Therapeutics delays publication of 2023 resultsLSE:ARECArecor Therapeutics Plc
03/05/202417h44RNS Regulatory NewsArecor Therapeutics PLC Publication of Full Year Financial Results delayedLSE:ARECArecor Therapeutics Plc
29/04/202408h00RNS Regulatory NewsArecor Therapeutics PLC Notice of resultsLSE:ARECArecor Therapeutics Plc
23/04/202412h02Alliance NewsAlliance NewsArecor chief financial officer to leave in July after five yearsLSE:ARECArecor Therapeutics Plc
23/04/202408h00RNS Regulatory NewsArecor Therapeutics PLC BOARD CHANGELSE:ARECArecor Therapeutics Plc
12/03/202413h16Alliance NewsAlliance NewsArecor to develop "holy grail" diabetes treatment with partner TRxLSE:ARECArecor Therapeutics Plc
12/03/202409h58RNS Regulatory NewsArecor Therapeutics PLC Arecor and TRx Biosciences research collaborationLSE:ARECArecor Therapeutics Plc
29/02/202420h42Alliance NewsAlliance NewsEARNINGS AND TRADING: East Star, Getech strike Kazakhstan JVLSE:ARECArecor Therapeutics Plc
29/02/202408h00RNS Regulatory NewsArecor Therapeutics PLC Arecor announces launch of Ogluo® in NetherlandsLSE:ARECArecor Therapeutics Plc
01/02/202415h24Alliance NewsAlliance NewsArecor Therapeutics hails Arestat as 2023 performance "strong"LSE:ARECArecor Therapeutics Plc
01/02/202408h00RNS Regulatory NewsArecor Therapeutics PLC Year End Trading UpdateLSE:ARECArecor Therapeutics Plc
23/01/202422h47Alliance NewsAlliance NewsIN BRIEF: Arecor pleased as investee Inhibrx sells therapy to SanofiLSE:ARECArecor Therapeutics Plc
23/01/202417h58UK RegulatoryArecor Therapeutics PLC Arecor announces update on INBRX-101LSE:ARECArecor Therapeutics Plc
18/01/202419h26Alliance NewsAlliance NewsTRADING UPDATES: Patent boosts for DG Innovate and Arecor TherapeuticsLSE:ARECArecor Therapeutics Plc
18/01/202408h00UK RegulatoryArecor Therapeutics PLC Arecor granted key European patentLSE:ARECArecor Therapeutics Plc
08/01/202412h34Alliance NewsAlliance NewsArecor expands speciality hospital collaboration with partnerLSE:ARECArecor Therapeutics Plc
08/01/202408h00UK RegulatoryArecor Therapeutics PLC Expansion of specialty hospital collaborationLSE:ARECArecor Therapeutics Plc
03/01/202408h00UK RegulatoryArecor Therapeutics PLC Appointment of SVP for Tetris Pharma LtdLSE:ARECArecor Therapeutics Plc
 Showing the most relevant articles for your search:LSE:AREC

Dernières Valeurs Consultées

EU
CAFTB
Credit Agricole CIB Fina...
BIT
W439T2
UBS
NASDAQ
IASGE
Integrated Alarm Services
EU
NL0009706597
Van Lanschot Bankiers F ...
USOTC
HNTIY
Hunting (PK)
CRTO
UMAUSDT
UMA Voting Token v1
EU
ALPER
La Perla Fashion Holding...
TG
A28R7C
Altice Financing
BOV
BOVA11
Ishares Ibovespa Fundo D...
NYSE
KNXA
NASDAQ
AUID
authID
GATE
RUFFETH
Ruff
LSE
FJ20
Lon Pow 43
BIT
F37670
Vontobel Financial Produ...
BIT
F21532
Vontobel Financial Produ...
USOTC
LGCP
Legion Capital (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés